Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH EBITDA

EBITDA at other companies

Opko Health logo
Opko HealthOPK
-$28.82M+34.0%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
-$59.75M-61.9%
Pfizer logo
PfizerPFE
——
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
——
Viatris logo
ViatrisVTRS
——
AptarGroup logo
AptarGroupATR
——

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.4%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

$13.6Mebit+
$14.3MDepreciation Depletion & Amortization
=$27.98M

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's EBITDA?
Amphastar Pharmaceuticals (AMPH) reported EBITDA of $27.98M in Q1 2026.
How has Amphastar Pharmaceuticals's EBITDA changed year-over-year?
Amphastar Pharmaceuticals's EBITDA decreased by 45.0% year-over-year, from $50.9M to $27.98M.
What is the long-term trend for Amphastar Pharmaceuticals's EBITDA?
Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's EBITDA has grown at a 20.6% compound annual growth rate (CAGR), from $93.15M to $197.1M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.